Sale

Femtech Market

Global Femtech Market Share, Report, Analysis, Forecast: By Product Type: Diagnostics, Monitoring, Therapeutic, Consumer Products; By Application: General Health and Wellness, Maternity Care, Menstrual Health, Pelvic and Uterine Healthcare, Others; By Distribution Channel; By End User; Regional Analysis; Competitive Landscape; 2024-2032

Global Femtech Market Outlook

The global femtech market size was valued at USD 28.7 billion in 2023, driven by the increasing focus of startups on developing improved healthcare for specific concerns among women across the globe. The market size is anticipated to grow at a CAGR of 12.4% during the forecast period of 2024-2032 to achieve a value of USD 87.9 billion by 2032.

 

femtech market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Femtech Market Overview

Femtech refers to the category of technologies, tools, and devices that are used to focus on the health of women. It includes software, products, tests, and services, ranging from consumer products and apps to diagnostics and telehealth. Femtech focuses on products that utilise technology in a manner to optimise the health of women, proactively and in case of health concerns.

 

An increase in the need for digital technology in the healthcare sector is driving the growth of the global femtech market. In the upcoming years, the rising popularity of wearable technology to track and monitor the well-being of patients is anticipated to increase the usage of femtech devices.

 

According to the femtech market analysis, growing concerns about women's health and wellness are projected to fuel the growth of the market for femtech products over the forecast period. As access to women's care in rural regions increases and the awareness regarding wellness in developing countries improves, the market is expected to witness significant demand.

 

Increasing measures undertaken by the governments of developing countries to boost the adoption of femtech products is one of the key femtech market trends. Femtech products available in the market address issues with pregnancy, reproduction, chronic illnesses, mental health, and general wellness, among others.

 

As per femtech market research, an increasing number of start-ups are concentrating on developing easy solutions for women's healthcare by comprehending their unique demands and difficulties, supporting market expansion. With more start-ups entering the market and raising awareness of femtech solutions, modernized and effective services will likely be available to more women all over the world.

 

Rising Application to Drive the Market Growth

Pregnancy and nursing care applications of femtech are expected to account for a substantial portion of the market as more women become pregnant at later ages and complications related to pregnancy and nursing increase. The rising demand for new and innovative products, including smart breast pumps is expected to drive the femtech market worth.

 

Also, it is anticipated that rising female awareness of contemporary technologies available that can aid in pregnancy and nursing and healthcare programs of various governments will further fuel the femtech market growth. The need for nursing care is anticipated to increase due to growing knowledge of the benefits of nursing and the rising availability of femtech solutions on digital platforms for easy diagnosis and monitoring. A surge in demand for higher-quality supplies and products used in pregnancy and nursing care is further boosting the femtech market value.

 

Increasing Fund Raisers

In Jan 2023, Oula, a New York-based maternity clinic focused on pregnancy and childbirth was founded on the belief that improving the experience will lead to better health outcomes and lower costs, raised USD 19.1 million in Series A funding.

 

The company plans to use the funds to improve its full-service maternity care including prenatal, delivery, and postpartum, as well as to increase the availability of group support and sonography services. This announcement has been at a crucial time, as maternal mortality rates in the United States are rising (especially for Black women), restrictions on reproductive rights are being imposed, and parents are facing a hard time, from a lack of accessible childcare to the absence of paid family leave.

 

Data in the factsheet curated by the World Health Organization showcase that an estimated 287,000 women died during and after pregnancy and childbirth in 2020. Almost 95% of all maternal deaths occurred in low and lower-middle-income countries in 2020, and most could have been prevented.  This data showcases the urgency to bring treatments for women facing difficulties during and after pregnancy. This urgency is significant to realize as it is high time now and with all the advancements going around in the healthcare domain, it is important to make some exclusive changes and improvements in the domain of women's health to bolster the global femtech market growth in the forecast period.

 

Funding activities as mentioned play an important role in the development of the market as it will enable further advancements of technologies and systems to provide targeted and effective maternity healthcare.

 

Market Launches Boosting the Demand

In July 2023, award-winning gynecological health startup Daye announced the launch of the world’s first virtual Period Pain Clinic to help women and assigned female at birth (AFAB) individuals identify the root cause of their period pain and gain easy access to diagnostic information to help them manage their symptoms appropriately.

 

In collaboration with NHS GPs, gynecologists, and chronic pelvic pain specialists, Daye developed a groundbreaking new service called Period Pain Clinic (PPC) to help women comprehend and manage their period discomfort conveniently and affordably. This new service conducts a thorough assessment of a patient's symptoms and offers private consultations with a range of specialists, including sexual health nurses, gynecologists, pelvic pain and fertility specialists, nutritionists, dermatologists, breathwork coaches, acupuncturists, and more.

 

Professionally trained healthcare professionals are available in the facility to enable a faster diagnosis of the root cause of an individual’s period pain and conditions such as endometriosis, adenomyosis, polycystic ovarian syndrome (PCOS), fibroids, and other conditions associated with chronic pelvic pain. These professionals can also address other symptoms that are connected indirectly and are unmanaged, including infertility, hair loss, obesity, and severe acne.

 

Such exclusive moves to maintain dignity as well as provide convenience with comfort to patients suffering from severe menstrual discomfort and other related symptoms are anticipated to foster the market growth.

 

femtech market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Femtech Market Segmentations

Market Breakup by Product Type

  • Diagnostics
  • Monitoring
  • Therapeutic
  • Consumer Products

 

Market Breakup by Application

  • General Health and Wellness
  • Maternity Care
  • Menstrual Health
  • Pelvic and Uterine Healthcare
  • Cancer and Chronic Disease

 

Market by Distribution Channel

  • Retail
  • Online

 

Market Breakup by End User

  • Direct-to-consumer
  • Hospitals
  • Surgical Centers
  • Fertility Clinics
  • Diagnostics Centers

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

femtech market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Femtech Market Regional Analysis

North America is dominating the market for femtech due to factors such as the rising prevalence of chronic conditions in women, the increase in infertility, and the growing awareness of femtech products and services among women. The market for femtech is expanding in the United States and other nations in the region as a result of the high incidences of cancer among women and the growing prevalence of lifestyle-related illnesses.

 

The expansion of the market in the North American region will also be aided by the increase in investments by the key players in the region, improved healthcare infrastructure, and rising knowledge of illnesses affecting women. With a sizable women workforce that continues to grow, more women are prioritizing their health and seeking technologies to support positive health, creating a sizable demand on the femtech market map.

 

In September 2023, a Chicago maternal health start-up Partum Health raised USD 3.1 million in seed round funding to improve maternal health outcomes in the United States. Research has shown that each year thousands of women face traumatic pregnancy, childbirth, and postpartum experiences that are largely preventable. Two factors that significantly contribute to the nation’s current maternal health crisis include the relative undersupply of maternity care providers and a lack of postpartum support. Partum Health aims to address and fulfil these crucial gaps of unmet needs by collaborating with obstetricians and midwives to provide patients with complementary and specialized care. Parum Health is also building a model that combines the convenience of mobile apps, chat, and on-demand care with hands-on support so that families can conveniently receive the care. The increasing focus of femtechs on providing convenient yet advanced healthcare is poised to play a crucial role in the femtech market growth during the forecast growth.

 

Global Femtech Market: Competitor Landscape

In May 2023, Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced certain commercial changes and plans to optimize its strategy and commercial structure to highly focus business activities on accelerating test adoption and revenue at significantly reduced operating costs.

 

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Flo Health Inc.
  • Clue Blowink GmbH
  • Glow Inc.
  • Natural Cycles USA Corp
  • Withings
  • Fitbit Inc.
  • Chiaro Technology Ltd.
  • Joylux Inc.
  • Coroflo Ltd.
  • HeraMED
  • Sera Prognostics
  • iSono Health, Inc.
  • Maven Clinic Co.
  • Ovia Health
  • Willow Innovations, Inc.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Application
  • Distribution Channel
  • End User
  • Region
Breakup by Product Type
  • Diagnostics
  • Monitoring
  • Therapeutic
  • Consumer Products
Breakup by Application
  • General Health and Wellness
  • Maternity Care
  • Menstrual Health
  • Pelvic and Uterine Healthcare
  • Cancer and Chronic Disease
Breakup by Distribution Channel
  • Retail 
  • Online
Breakup by End User
  • Direct-to-consumer
  • Hospitals
  • Surgical Centers
  • Fertility Clinics
  • Diagnostics Centers
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Flo Health Inc.
  • Clue Blowink GmbH
  • Glow Inc.
  • Natural Cycles USA Corp
  • Withings
  • Fitbit Inc.
  • Chiaro Technology Ltd.
  • Joylux Inc.
  • Coroflo Ltd.
  • HeraMED
  • Sera Prognostics
  • iSono Health, Inc.
  • Maven Clinic Co.
  • Ovia Health
  • Willow Innovations, Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Femtech Market Overview 

    3.1    Global Femtech Market Historical Value (2017-2023) 
    3.2    Global Femtech Market Forecast Value (2024-2032)
4    Global Femtech Market Landscape*
    4.1    Global Femtech: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Femtech: Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Application 
5    Global Femtech Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
        5.5    Key Price Indicators
        5.6    Industry Events, Initiatives, and Trends  
        5.7    Value Chain Analysis
6    Global Femtech Market Segmentation (2017-2032 )
    6.1    Global Femtech Market (2017-2032) by Product Type 
        6.1.1    Market Overview    
        6.1.2    Diagnostics
        6.1.3    Monitoring
        6.1.4    Therapeutic
        6.1.5    Consumer Products 
    6.2    Global Femtech Market (2017-2032) by Application
        6.2.1    Market Overview    
        6.2.2    General Health and Wellness
        6.2.3    Maternity Care
        6.2.4    Menstrual Health
        6.2.5    Pelvic and Uterine Healthcare
        6.2.6    Cancer and Chronic Disease 
    6.3    Global Femtech Market (2017-2032) by Distribution Channel 
        6.3.1    Market Overview    
        6.3.2    Retail 
        6.3.3    Online 
    6.4    Global Femtech Market (2017-2032) by End User 
        6.4.1    Market Overview    
        6.4.2    Direct-to-consumer
        6.4.3    Hospitals
        6.4.4    Surgical Centers
        6.4.5    Fertility Clinics
        6.4.6    Diagnostics Centers 
    6.5    Global Femtech Market (2017-2032) by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Femtech Market (2017-2032)
    7.1    North America Femtech Market (2017-2032) by Product Type 
        7.1.1    Market Overview    
        7.1.2    Diagnostics
        7.1.3    Monitoring
        7.1.4    Therapeutic
        7.1.5    Consumer Products  
    7.2    North America Femtech Market (2017-2032) by Application
        7.2.1    Market Overview    
        7.2.2    General Health and Wellness
        7.2.3    Maternity Care
        7.2.4    Menstrual Health
        7.2.5    Pelvic and Uterine Healthcare
        7.2.6    Cancer and Chronic Disease 
    7.3    North America Femtech Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Femtech Market (2017-2032)
    8.1    Europe Femtech Market (2017-2032) by Product Type  
        8.1.1    Market Overview    
        8.1.2    Diagnostics
        8.1.3    Monitoring
        8.1.4    Therapeutic
        8.1.5    Consumer Products 
    8.2    Europe Femtech Market (2017-2032) by Application 
        8.2.1    Market Overview    
        8.2.2    General Health and Wellness
        8.2.3    Maternity Care
        8.2.4    Menstrual Health
        8.2.5    Pelvic and Uterine Healthcare
        8.2.6    Cancer and Chronic Disease 
    8.3    Europe Femtech Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Femtech Market (2017-2032)
    9.1    Asia Pacific Femtech Market (2017-2032) by Product Type  
        9.1.1    Market Overview    
        9.1.2    Diagnostics
        9.1.3    Monitoring
        9.1.4    Therapeutic
        9.1.5    Consumer Products 
    9.2    Asia Pacific Femtech Market (2017-2032) by Application 
        9.2.1    Market Overview    
        9.2.2    General Health and Wellness
        9.2.3    Maternity Care
        9.2.4    Menstrual Health
        9.2.5    Pelvic and Uterine Healthcare
        9.2.6    Cancer and Chronic Disease 
    9.3    Asia Pacific Femtech Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    ASEAN
        9.3.5    Others
10    Latin America Femtech Market (2017-2032)
    10.1    Latin America Femtech Market (2017-2032) by Product Type  
        10.1.1    Market Overview    
        10.1.2    Diagnostics
        10.1.3    Monitoring
        10.1.4    Therapeutic
        10.1.5    Consumer Products  
    10.2    Latin America Femtech Market (2017-2032) by Application 
        10.2.1    Market Overview    
        10.2.2    General Health and Wellness
        10.2.3    Maternity Care
        10.2.4    Menstrual Health
        10.2.5    Pelvic and Uterine Healthcare
        10.2.6    Cancer and Chronic Disease 
    10.3    Latin America Femtech Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Femtech Market (2017-2032)
    11.1    Middle East and Africa Femtech Market (2017-2032) by Product Type  
        11.1.1    Market Overview    
        11.1.2    Diagnostics
        11.1.3    Monitoring
        11.1.4    Therapeutic
        11.1.5    Consumer Products 
    11.2    Middle East and Africa Femtech Market (2017-2032) by Application 
        11.2.1    Market Overview    
        11.2.2    General Health and Wellness
        11.2.3    Maternity Care
        11.2.4    Menstrual Health
        11.2.5    Pelvic and Uterine Healthcare
        11.2.6    Cancer and Chronic Disease 
    11.3    Middle East and Africa Femtech Market (2017-2032) by Country
        11.3.1    Saudi Arabia
        11.3.2    United Arab Emirates
        11.3.3    Nigeria
        11.3.4    South Africa
        11.3.5    Others
12    Regulatory Framework
    12.1     Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2          Analysis by Publication Year
    13.3          Analysis by Issuing Authority
    13.4          Analysis by Patent Age
    13.5          Analysis by CPC Analysis
    13.6          Analysis by Patent Valuation 
    13.7          Analysis by Key Players
14    Grants Analysis
    14.1          Analysis by Year
    14.2          Analysis by Amount Awarded
    14.3        Analysis by Issuing Authority
    14.4        Analysis by Grant Application
    14.5        Analysis by Funding Institute
    14.6        Analysis by NIH Departments
    14.7        Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1           Analysis by Funding Instances
    15.2        Analysis by Type of Funding
    15.3        Analysis by Funding Amount
    15.4        Analysis by Leading Players
    15.5        Analysis by Leading Investors
    15.6        Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2          Analysis by Type of Partnership
    16.3          Analysis by Leading Players
    16.4          Analysis by Geography
17    Supplier Landscape
    17.1    Flo Health Inc. 
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Clue Blowink GmbH 
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Glow Inc. 
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Natural Cycles USA Corp 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Withings 
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Fitbit Inc. 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Chiaro Technology Ltd. 
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Joylux Inc. 
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Coroflo Ltd. 
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    HeraMED 
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Sera Prognostics 
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    iSono Health, Inc. 
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    Maven Clinic Co. 
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
    17.14    Ovia Health 
        17.14.1    Financial Analysis
        17.14.2    Product Portfolio
        17.14.3    Demographic Reach and Achievements
        17.14.4    Mergers and Acquisitions
        17.14.5    Certifications
    17.15    Willow Innovations, Inc. 
        17.15.1    Financial Analysis
        17.15.2    Product Portfolio
        17.15.3    Demographic Reach and Achievements
        17.15.4    Mergers and Acquisitions
        17.15.5    Certifications
List not exhaustive
18    Global Femtech Market – Distribution Model (Additional Insights)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

Key Questions Answered in the Report

The market attained a value of about USD 28.7 billion in 2023, driven by the increasing health issues in women.

The market is anticipated to grow at a CAGR of 12.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 87.9 billion by 2032.

Factors such as increasing digitization in the healthcare sector, rising popularity of wearable technology, increasing awareness about women health, increasing government initiatives to address crucial gaps of unmet medical needs in women healthcare and fundraising activities are aiding the market demand.

The market growth is influenced by trends such as increasing strategic launches of healthcare services and clinics by market players and strategic changes in existing settings.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

Types of products include diagnostics, monitoring, therapeutic, and consumer products.

Femtech finds wide applications in general health and wellness, maternity care, menstrual health, pelvic and uterine healthcare, cancer, and chronic disease.

Distribution channels include retail and online.

End users in the market include direct-to-consumer, hospitals, surgical centers, fertility clinics, and diagnostics centers.

Key players involved in the market are Flo Health Inc., Clue Blowink GmbH, Glow Inc., Natural Cycles USA Corp, Withings, Fitbit Inc., Chiaro Technology Ltd., Joylux Inc., Coroflo Ltd., HeraMED, Sera Prognostics, iSono Health, Inc., Maven Clinic Co., Willow Innovations, Inc., and Ovia Health.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER